293 related articles for article (PubMed ID: 6086533)
1. Complement components, complement activation, and acute phase response in systemic lupus erythematosus.
Sturfelt G; Sjöholm AG
Int Arch Allergy Appl Immunol; 1984; 75(1):75-83. PubMed ID: 6086533
[TBL] [Abstract][Full Text] [Related]
2. Complement components, C1 activation and disease activity in SLE.
Sturfelt G; Sjöholm AG; Svensson B
Int Arch Allergy Appl Immunol; 1983; 70(1):12-8. PubMed ID: 6293980
[TBL] [Abstract][Full Text] [Related]
3. Sequential studies of complement activation in systemic lupus erythematosus.
Sturfelt G; Johnson U; Sjöholm AG
Scand J Rheumatol; 1985; 14(2):184-96. PubMed ID: 4001891
[TBL] [Abstract][Full Text] [Related]
4. Prospective analysis of C1 dissociation and complement activation in patients with systemic lupus erythematosus.
Jonsson H; Sturfelt G; Mårtensson U; Truedsson L; Sjöholm AG
Clin Exp Rheumatol; 1995; 13(5):573-80. PubMed ID: 8575134
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of (C1INH)2 C1r-C1s complexes in glomerulonephritis as an indicator of C1 activation.
Waldo FB; West CD
Clin Immunol Immunopathol; 1987 Feb; 42(2):239-49. PubMed ID: 3026704
[TBL] [Abstract][Full Text] [Related]
6. C1 subcomponent complexes and C2 cleavage in active systemic lupus erythematosus.
Jonsson H; Sjöholm AG; Mårtensson U; Laurell AB; Sturfelt G
Complement Inflamm; 1991; 8(1):1-12. PubMed ID: 2049932
[TBL] [Abstract][Full Text] [Related]
7. Circulating immune complexes and C1 activation in patients with rapidly progressive glomerulonephritis, before and after treatment with immunosuppression and plasma exchange.
Sjöholm AG; Brun C; Larsen S; Thysell H
Int Arch Allergy Appl Immunol; 1983; 72(1):9-15. PubMed ID: 6874103
[TBL] [Abstract][Full Text] [Related]
8. Hypocomplementemia with low C1s-C1 inhibitor complex in systemic lupus erythematosus.
Lockshin MD; Qamar T; Redecha P; Harpel PC
Arthritis Rheum; 1986 Dec; 29(12):1467-72. PubMed ID: 3492208
[TBL] [Abstract][Full Text] [Related]
9. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
Daha MR; Hazevoet HM; Hermans J; van Es LA; Cats A
Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610
[TBL] [Abstract][Full Text] [Related]
10. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
Perrin LH; Lambert PH; Miescher PA
J Clin Invest; 1975 Jul; 56(1):165-76. PubMed ID: 1141431
[TBL] [Abstract][Full Text] [Related]
11. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
[TBL] [Abstract][Full Text] [Related]
12. Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE).
Lloyd W; Schur PH
Medicine (Baltimore); 1981 May; 60(3):208-17. PubMed ID: 7231154
[TBL] [Abstract][Full Text] [Related]
13. Complement components and activation in primary biliary cirrhosis.
Lindgren S; Laurell AB; Eriksson S
Hepatology; 1984; 4(1):9-14. PubMed ID: 6420306
[TBL] [Abstract][Full Text] [Related]
14. Differential characteristics of immune-bound antibodies in diffuse proliferative and membranous forms of lupus glomerulonephritis.
Roberts JL; Wyatt RJ; Schwartz MM; Lewis EJ
Clin Immunol Immunopathol; 1983 Nov; 29(2):223-41. PubMed ID: 6605223
[TBL] [Abstract][Full Text] [Related]
15. [Components of the classical complement pathway in systemic lupus erythematosus].
Maillet F; Goetz J; Hauptmann G; Clauvel JP; Mery JP; Kahn MF; Kazatchkine M
Presse Med; 1987 Mar; 16(8):378-82. PubMed ID: 2950498
[TBL] [Abstract][Full Text] [Related]
16. [Activity of total complement and concentration of its components C1q, C3, C4 and C1-inactivator in cancer].
Matoses Cuquerella S; O'Connor Miquel C; Lluch Hernández AM; García-Conde Bru J
Med Clin (Barc); 1988 Dec; 91(20):769-74. PubMed ID: 3266280
[No Abstract] [Full Text] [Related]
17. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
[TBL] [Abstract][Full Text] [Related]
18. Atypical hypocomplementemic vasculitis syndrome in a child.
Waldo FB; Leist PA; Strife CF; Forristal J; West CD
J Pediatr; 1985 May; 106(5):745-50. PubMed ID: 2987470
[TBL] [Abstract][Full Text] [Related]
19. Inherited complement deficiency states and SLE.
Rynes RI
Clin Rheum Dis; 1982 Apr; 8(1):29-47. PubMed ID: 6288318
[No Abstract] [Full Text] [Related]
20. C-reactive protein and complement components but not other acute-phase reactants discriminate between clinical subsets and organ damage in systemic lupus erythematosus.
Amezcua-Guerra LM; Springall R; Arrieta-Alvarado AA; Rodríguez V; Rivera-Martinez E; Castillo-Martinez D; Bojalil R
Clin Lab; 2011; 57(7-8):607-13. PubMed ID: 21888025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]